Robert Rollins has extensive expertise in the fields of cancer epigenetics and oncology, with a career spanning over two decades. Rollins began at Yale University School of Medicine as a Scientific Technician, contributing to molecular biology and biochemical genetics. Following this, a role as a Postdoctoral Research Fellow at Columbia University focused on cancer epigenetics under Dr. Timothy Bestor. Subsequent positions included various scientist roles at Wyeth Research and Pfizer, culminating in a Senior Director position in Oncology Scientific Strategy & External Evaluation at Pfizer since 2020. Additionally, Rollins has experience in product development at Enzo Life Sciences, Inc. and holds a Bachelor’s Degree in Biology from Colgate University and a Ph.D. in Molecular Biology and Genetics from Weill Cornell Graduate School of Medical Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices